Summary:
The CYPRESS study will evaluate the safety and effectiveness of an investigational drug for Post-Traumatic Stress Disorder (PTSD).
Qualified Participants Must:
• You may be able to take part in this clinical research study if you:- Are 18 to 65 years of age
- Have had PTSD symptoms for at least 6 months prior to this study
Qualified Participants May Receive:
If you take part, you will be in this clinical research study for approximately 17 weeks. All study-related visits, tests, and drugs will be provided at no cost. In addition, reimbursement for study-related travel may be provided.